BEIJING, Nov. 20,
2023 /PRNewswire/ -- Concord Medical Services
Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM),
a healthcare provider specialized in cancer treatment, research,
education and prevention by establishing proton centers and cancer
hospitals and operating an extensive network of radiotherapy and
diagnostic imaging centers in China, today announced that it will hold its
2023 annual general meeting of shareholders (the "Meeting") on
December 26, 2023, at 10:00 a.m. (Beijing Time). The meeting will be
held at Room 26A1-26A5, East Tower, Hanwei Building, No. 7 Guanghua
Road, Chaoyang District, Beijing,
China. The shareholder record date is November 27, 2023. A copy of the notice of
Meeting is available on the Company's investor relations website
No proposal will be submitted for shareholder approval at the
Meeting. Instead, the Meeting will be convened for shareholders who
are entitled to vote to discuss Company affairs with management.
Concord Medical's annual report on Form 20-F filed with the U.S.
Securities and Exchange Commission, containing the Company's
audited financial statements for the financial year ended
December 31, 2022, is available in
the Investor Relations section of the Company's website
at http://ir.ccm.cn. The Form 20-F is also available on the
SEC's website at http://www.sec.gov.
About Concord Medical
Concord Medical Services Holdings Limited is a healthcare
provider featuring a full cycle of premium oncology services
including cancer diagnosis, treatment, education and prevention.
The Company focuses on providing multidisciplinary cancer care in
all aspects of oncology healthcare services in its cancer hospitals
and equipping them with technologically advanced equipment such as
the state-of-the-art proton therapy system. The Company is striving
to improve the quality and accessibility of cancer care through its
network of self-owned cancer hospitals and clinics as well as
partnered hospitals across China.
For more information, please see http://ir.ccm.cn.
Safe Harbor Statement
This announcement contains forward-looking statements. These
forward-looking statements can be identified by words or phrases
such as "will," "expects," "anticipates," "future," "intends,"
"plans," "believes," "estimates" and similar expressions.
Forward-looking statements are inherently subject to uncertainties
and contingencies beyond the Company's control and based upon
premises with respect to future business decisions, which are
subject to change. A number of important factors could cause actual
results to differ materially from those contained in any
forward-looking statement. The Company does not undertake any
obligation to update any forward-looking statement, except as
required under applicable law.
SOURCE Concord Medical Services Holdings Limited